IgE Antibodies against Cancer: Efficacy and Safety. (2020)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/antib9040055
PubMed Identifier: 33081206
Publication URI: http://europepmc.org/abstract/MED/33081206
Type: Journal Article/Review
Volume: 9
Parent Publication: Antibodies (Basel, Switzerland)
Issue: 4
ISSN: 2073-4468